Identification of a prognostic signature in colorectal cancer using combinatorial algorithm-driven analysis

Area of Science:

• Oncology
• Biomarker Discovery
• Computational Biology

Background:

• Colorectal carcinoma is a leading cause of cancer mortality.
• Clinicopathological parameters offer prognostic insights, but molecular biomarkers can enhance accuracy.
• Identifying optimal biomarker combinations is crucial for improved prognostic tools.

Purpose of the Study:

• To develop an effective methodology for identifying optimal biomarker combinations for colorectal cancer prognosis.
• To identify a novel molecular biomarker signature with significant prognostic power.
• To validate the identified signature in an external cohort.

Main Methods:

• Utilized a large dataset of 66 immunohistochemistry-based biomarkers.
• Employed an iterative algorithm to screen biomarkers and evaluate combinatorial interactions based on statistical power.
• Assessed the prognostic significance and independence of the identified biomarker signature.

Main Results:

• A six-biomarker signature (STAT1, UCP1, p-cofilin, LIMK2, FOXP3, and ICOS) was identified as the optimal combination.
• This signature demonstrated significant association with overall survival (p < 0.001) and was independent of clinical factors.
• Validation in an external cohort confirmed the signature's significant association with prognosis (p = 0.007).

Conclusions:

• An innovative discovery approach for identifying biomarker combinations was developed and optimized.
• A novel protein signature for colorectal cancer prognosis was identified.
• This signature holds potential as an independent prognostic method and for therapeutic interventions.